PAS
IDYA icon

Point72 Asia (Singapore)’s IDEAYA Biosciences IDYA Stock Holding History

Point72 Asia (Singapore)’s Portfolio IDYA Stock Details IDYA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		$124K Buy
4,561
+4,085
+858% +$98.8K 0.02% 401
2025
Q2 		$10K Buy
+476
New +$9.13K ﹤0.01% 798

Other funds holding IDYA

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return

Point72 Asia (Singapore)'s IDYA Position: Q3 2025 in Review

Point72 Asia (Singapore) increased its IDEAYA Biosciences (IDYA) stake by 858% in Q3 2025, buying an estimated $98.8K and bringing the position to 4,561 shares worth $124K. The position accounts for 0.02% of the portfolio, ranked #401.

Point72 Asia (Singapore) first reported a position in IDYA in Q2 2025 and has held it in 2 quarters since. 224 funds tracked by Wall St. Rank hold IDYA as of Q3 2025.

  • Point72 Asia (Singapore) held 4,561 shares of IDEAYA Biosciences worth $124K as of Q3 2025.
  • Point72 Asia (Singapore) bought 4,085 IDEAYA Biosciences shares in Q3 2025, an estimated $98.8K.
  • IDEAYA Biosciences made up 0.02% of Point72 Asia (Singapore)'s portfolio in Q3 2025, its #401 holding.
  • Point72 Asia (Singapore) first reported a position in IDEAYA Biosciences in Q2 2025 and has held it in 2 quarters since.
  • 224 funds tracked by Wall St. Rank held IDEAYA Biosciences as of Q3 2025.

Based on Point72 Asia (Singapore)'s 13F filing for Q3 2025, filed 14 Nov 2025.